Anca M. Avram is Professor of Radiology and Medicine at Case Western Reserve University/MetroHealth Center. Her clinical and research interests are centered on systemic radioisotope therapies, including radioactive iodine therapy for treatment of hyperthyroidism and thyroid cancer, radioimmunotherapy for lymphoma, and targeted radioligand therapy for metastatic neuroendocrine tumors and prostate cancer. She developed a strong nuclear medicine therapy program at the University of Michigan, Ann Arbor. In 2022 she was recruited at Case Western Reserve University/MetroHealth in Cleveland, Ohio, where she currently serves as the Director of Nuclear Medicine and Endocrinology Divisions. Her academic contributions include 84 peer-reviewed publications and 16 book chapters.

Dr. Murat Fani Bozkurt is a professor of Nuclear Medicine at Hacettepe University Hospital in Ankara, Turkey. He is the immediate-past president of the Turkish Society of Nuclear Medicine (TSNM) and editor-in-chief of Molecular Imaging and Radionuclide Therapy (MIRT). He completed a research fellowship in oncological PET imaging at the University of Pennsylvania PET Center in 2003, and a visiting scientist program in Cardiac PET imaging at Harvard University Brigham and Women's Hospital in 2009. He has served as Head of the Department of Nuclear Medicine at Hacettepe University since 2022. His main areas of interest are nuclear oncology, NET and prostate theranostics, Y-90 microsphere therapy, nuclear cardiology, and intraoperative gamma probe applications.

Dr John Buscombe is a recently retired nuclear medicine physician having worked as a specialist at the Royal Free Hospital, London and the Cambridge University Hospitals. He was also a professor of nuclear medicine at the University of Pretoria from 2010–2025. He has a long life interest in theragnostics, nuclear cardiology and infection imaging as well as education in nuclear medicine. He has 10,000 citations of his 270 peer reviewed papers.

Dr. Savvas Frangos is a nuclear medicine specialist at the Nuclear Medicine Department and the Thyroid Cancer Clinic of the Bank of Cyprus Oncology Center in Nicosia, Cyprus. He is a Fellow of the European Board of Nuclear Medicine and currently serves as President of the World Federation of Nuclear Medicine and Biology (WFNMB) and President of the Cyprus Society of Nuclear Medicine. He is a member of the editorial boards of the European Journal of Nuclear Medicine, The EANM Journal and the European Journal of Hybrid Imaging, as well as co-editor of the Hellenic Journal of Nuclear Medicine.

Dr. Iagaru is a Professor of Radiology - Nuclear Medicine at Stanford University Medical Center. He completed medical school at Carol Davila University of Medicine, Bucharest, Romania. His research interests include PET/MRI and PET/CT for early cancer detection, as well as clinical translation of novel radiopharmaceuticals for imaging and therapy. Dr. Iagaru has received several awards including the SNM 2009 Image of the Year Award, the 2022 Sanjiv Sam Gambhir Trailblazer Award SNMMI, and the 2023 Presidential Award SNMMI. He published more than 245 papers in peer-reviewed journals, as well as 9 book chapters and 1 book.

Ora Israel is Emeritus Professor of Imaging at the Rappaport School of Medicine, the Technion, in Haifa, Israel. Over more than four decades, her main scientific interests included multimodality imaging, in vivo radionuclide quantitation, and imaging of infection and inflammation. She has been involved in the development of hybrid imaging, SPECT/CT and PET/CT since its beginnings in the late 1990s. She is the author of four textbooks on Hybrid Imaging and over 220 scientific articles. Elected in 2018 as Fellow of the SNMMI (USA) — the first non-North American to receive this honor — and Honorary Member of the EANM in 2020.

Dr. Hossein Jadvar is a tenured Professor of Radiology with joint appointments in Urology, Radiation Oncology, and Biomedical Engineering at the University of Southern California (USC), Los Angeles, USA. He is a fellow and past president of both the ACNM and SNMMI. He serves as Chair for the U.S. NRC Advisory Committee on Medical Uses of Isotopes (ACMUI). He has written over 270 peer-reviewed journal articles, published 4 books and 41 book chapters, been awarded 9 U.S. and European patents, and has had more than 300 invited lectureships and visiting professorships internationally.

Prof. Kairemo graduated with a MSc (Eng) from Helsinki University of Technology in 1980, followed by an MD (1986) and PhD (1993) at the University of Helsinki. He is licensed as a medical specialist in Finland, Norway, Sweden, and Estonia. He served as Head of the Nuclear Medicine Division at Helsinki University Central Hospital (2004–2009) and has been Visiting Professor at the University of Texas MD Anderson Cancer Center in Houston since 2015. He is the past President (2024–2025) of WARMTH and Editor-in-Chief of the World Journal of Nuclear Medicine.

Prof. John T. Koutsikos is Chief of the Theranostics Nuclear Medicine Center at Henry Dunant Hospital, Athens, Greece. His clinical practice and research interests are imaging and therapy of thyroid cancer, neuroendocrine tumours and prostate cancer. Since 2019 he is the President of the Hellenic Society of Nuclear Medicine & Molecular Imaging. He is his country's delegate to the World Federation of Nuclear Medicine and Biology and also member of the EANM, SNMMI and WARMTH.

Riccardo Laudicella is a Nuclear Medicine Physician and Researcher at Messina University, where he obtained a PhD in "Bioengineering Applied to Medical Sciences". He also completed a 1.5-year research fellowship in Switzerland (Universitätsspital Zurich, ETH, and Kantonsspital Baden) in hybrid imaging of genito-urinary cancer, internal radiotherapy, and glucose metabolism. His main interests are dedicated to theranostics, PSMA PET with also AI applications.

Dr. Masha Maharaj is a highly accomplished Nuclear Medicine Specialist with extensive expertise in theragnostics, oncology, molecular imaging, and interventional nuclear medicine. She leads multiple imaging and therapy centres in KwaZulu-Natal, South Africa, and Lagos, Nigeria. Renowned for her leadership in expanding radionuclide therapy across Africa, she holds key leadership roles in global nuclear medicine organisations (president-elect 2028–2029 WARMTH).

Professor dr. Daniela-Elena Oprea-Lager, MD, PhD, is nuclear medicine physician at the Department of Medical Imaging, Radboud University Medical Center, Nijmegen, the Netherlands. She is the chair of the Imaging Subcommittee Group 'Bone & Oligometastases' of the EORTC and Chair of the Foundation 'PSMA Forum NL'. She is a full-member of the Prostate Cancer Guidelines Panel within the EAU and member of the Oncology & Theranostics committee of the EANM. In 2024 she joined Radboud University Medical Center where she was appointed Professor Theranostics in 2025. Daniela authored more than 170 peer-reviewed journal publications.

Tim Van den Wyngaert, MD, PhD, is a nuclear medicine physician and professor at the University of Antwerp, and deputy head of the Department of Nuclear Medicine at Antwerp University Hospital, Belgium. His research focuses on molecular imaging, with a particular interest in bone SPECT/CT and the development of radiopharmaceuticals for imaging the tumor microenvironment. He serves as Chairman of the Young Professionals Council of the EANM and President of the Belgian Society of Nuclear Medicine (BELNUC). He is the European Lead of INSPIRE by EANM, the flagship workforce programme of the EANM.

Dr. David B. Weinreb is a nuclear radiologist at Saint Peter's Hospital in Albany, the capital city of New York State. He completed his undergraduate degree at Yale University, pursuing a double-major in Biochemistry and Geology. He obtained his medical degree at the Mount Sinai School of Medicine, followed by a residency in diagnostic radiology at the Hospital of Saint Raphael's in Connecticut and a fellowship in nuclear radiology at Stanford University in California. He has 15 years of post-training experience as a nuclear radiologist, with a specific clinical focus on oncologic imaging and PET/CT.